Cue Health rises as FDA allows emergency use of mpox test

Cue Health

20/03/2023 15:44

** Shares of medical testing company Cue Health Inc  HLTH.O 
rise 1.4% to $2.21
    ** Company says the U.S. FDA has granted emergency use
authorization (EUA) for its molecular test to detect the mpox
virus
    ** HLTH says the EUA marks its first non-COVID test to
receive FDA authorization
    ** The test is authorized to be used in professional
point-of-care settings - HLTH 
    ** WHO in November had said it would start using a new
preferred term, "mpox", as a synonym for monkeypox to tackle
stigma
    ** Including session's moves, stock down ~77% in the past 12
months

 (Reporting by Mariam Sunny)
 ((Mariam.ESunny@thomsonreuters.com;))